Sharechat Logo

Argosy sells Auckland property for $10.4 million

Thursday 8th May 2014

Text too small?

Argosy Property, the fourth-largest listed property investor on the NZX by market value, has sold its underperforming Mount Wellington property in Auckland for $10.4 million.

The sale was a 2.7 percent premium to its March book value and is part of Argosy's plan to ditch underperforming assets, the company said in a statement. The Pacific Rise commercial property had an occupancy rate of about 75 percent according to Argosy's website, and has been bought by an owner-occupier.

"Returns from the property had suffered from long term vacancy issues and a short weighted average lease term," Argosy said.

Last December the company got rid of its underperforming Ellerslie holdings for $10.4 million, at 92 percent of its book value.

Shares in the company rose 0.5 percent to 95 cents. The stock has declined 8.5 percent over the past year underperforming the NZX 50 Index's 12 percent rise, while the property index, made up of 10 NZX-listed property stocks, has declined 1.1 percent in the past 12 months. The stock is rated an average of 'hold' based on five analysts surveyed by Reuters and has a median price target of $1.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors